Literature DB >> 8828245

Benzodiazepine types in high versus therapeutic dose dependence.

H Martínez-Cano1, A Vela-Bueno, M De Iceta, R Pomalima, I Martínez-Gras, M P Sobrino.   

Abstract

Two types of benzodiazepine dependence have been described: high vs. therapeutic dose dependence. So far, no systematic research has been conducted regarding the frequency with which the various benzodiazepines are represented in one type or the other. In this study, 153 dependent patients using 14 different benzodiazepines were evaluated to assess the prevalence of their use among high vs. therapeutic dose dependents. Triazolam was the single drug most frequently used by high-dose dependents, followed by Lorazepam. No significant differences were found among benzodiazepines regarding their use by therapeutic dose dependents. Our data shows that pharmacokinetic and pharmacodynamic factors appear to be related to the frequency with which the different benzodiazepines are used by high and therapeutic dose dependents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828245     DOI: 10.1046/j.1360-0443.1996.91811799.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians' attitudes toward benzodiazepine prescribing.

Authors:  Sibyl Anthierens; Inge Pasteels; Hilde Habraken; Pascale Steinberg; Tom Declercq; Thierry Christiaens
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

2.  Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up.

Authors:  Rolf van Hulten; K Bart Teeuw; Albert Bakker; Hubert G Leufkens
Journal:  Eur J Clin Pharmacol       Date:  2003-02-07       Impact factor: 2.953

Review 3.  The problems of long-term treatment with benzodiazepines and related substances.

Authors:  Katrin Janhsen; Patrik Roser; Knut Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2015-01-05       Impact factor: 5.594

4.  Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study.

Authors:  Yuichi Inoue; Yoshikazu Takaesu; Michinori Koebis
Journal:  BMC Psychiatry       Date:  2021-04-14       Impact factor: 3.630

5.  Anxiety and alcohol use disorders: comorbidity and treatment considerations.

Authors:  Joshua P Smith; Carrie L Randall
Journal:  Alcohol Res       Date:  2012

Review 6.  Benzodiazepine high-doses: The need for an accurate definition.

Authors:  Jean-Marc Cloos; Christopher Y S Lim Cow; Valéry Bocquet
Journal:  Int J Methods Psychiatr Res       Date:  2021-07-31       Impact factor: 4.035

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.